Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 24, 2023
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
[ Thu, Aug 24th 2023
] - WOPRAI
Robert Burns Reiterated (SWTX) at Strong Buy and Held Target at $66 on, Aug 24th, 2023
Robert Burns of HC Wainwright & Co., Reiterated "SpringWorks Therapeutics, Inc." (SWTX) at Strong Buy and Held Target at $66 on, Aug 24th, 2023.
Robert has made no other calls on SWTX in the last 4 months.
There are 2 other peers that have a rating on SWTX. Out of the 2 peers that are also analyzing SWTX, 0 agree with Robert's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Robert
- Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $49 on, Thursday, July 20th, 2023
- Peter Lawson of "Barclays" Maintained at Buy with Decreased Target to $41 on, Friday, April 28th, 2023
